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EIEWPOINT AND COMMENTARYDiastolic Blood Pressure and the J-Curve1827ranz H. Messerli, Gurusher S. Panjrath
1835ryan Williams
n a viewpoint article, Messerli and Panjrath review the literature regarding the potential
etrimental impact of lowering diastolic blood pressure beyond a certain threshold. They
rgue that most large trials of blood pressure-lowering have shown worse outcomes in those
ith the lowest diastolic blood pressure. Low diastolic pressure may be particularly dangerous
n patients with coronary stenosis, which further impedes coronary perfusion. In a response,
illiams argues that the reason these patients have worse outcomes is that they are at higher
isk to start with and were more likely to have had diabetes and coronary artery disease at
aseline. He expresses the need for more patient-level data to further understand this risk
efore changes to practice guidelines are implemented.CLINICAL RESEARCH ARDIAC RESYNCHRONIZATION THERAPY1837CRT Can Improve Outcomes in NYHA Functional Class I and II Patientslaude Daubert, Michael R. Gold, William T. Abraham, Stefano Ghio, Christian Hassager, Grahame Goode,
ama´s Szili-Török, Cecilia Linde, on behalf of the REVERSE Study Group
ardiac resynchronization therapy (CRT) is recommended as a Class I indication for patients
resenting in New York Heart Association (NYHA) functional class III or IV with a wide
RS and left ventricular (LV) dysfunction. The REVERSE (Resynchronization Reverses
emodeling in Systolic Left Ventricular Dysfunction) trial studied CRT in patients with a
ide QRS and LV dysfunction but who had never been highly symptomatic. All subjects
eceived CRT devices, but they were randomly assigned to a CRT ON or CRT OFF group
or 24 months. In the CRT ON group, 19% of patients worsened compared with 34% in the
RT OFF group. The LV end-systolic volume index decreased in the CRT ON group and
here were fewer HF hospitalizations. These results suggest that CRT prevents the
rogression of disease in patients with asymptomatic or mildly symptomatic LV dysfunction
ith a wide QRS.
ditorial Comment: Derek V. Exner, p. 1847(continued on page A-28)
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EEART FAILURE
1850osuvastatin Beneficial In Patients With Ischemic Cardiomyopathy Only if
BNP Is Lowohn G. F. Cleland, John J. V. McMurray, John Kjekshus, Jan H. Cornel, Peter Dunselman,
ândida Fonseca, Åke Hjalmarson, Jerzy Korewicki, Magnus Lindberg, Naresh Ranjith,
irk J. van Veldhuisen, Finn Waagstein, Hans Wedel, John Wikstrand, on behalf of the CORONA Study Group
atients with ischemic heart disease typically benefit from statin therapy, but the results in
atients with heart failure (HF) have been disappointing. Cleland and colleagues
ypothesized that there must be a transition point at which treatment with a statin becomes
utile and that amino-terminal brain natriuretic peptide (NT-proBNP) levels would identify
he transition point. Data was analyzed from the CORONA (Controlled Rosuvastatin
ultinational Trial in Heart Failure) trial, which randomized patients with ischemic
ardiomyopathy to rosuvastatin or placebo, and brain natriuretic peptide was measured at
aseline. Rosuvastatin significantly reduced the risk of the primary end point in patients in
he lowest NT-proBNP tertile, but there was no benefit in subjects with higher NT-proBNP
evels. These results suggest that the relative benefits of statins decline as the plasma
oncentration of NT-proBNP increases, so that an effect is no longer apparent above
03 pmol/l (868 pg/ml).ditorial Comment: Lori B. Daniels, Elizabeth Barrett-Connor, p. 1860ALVULAR HEART DISEASE1862Comparing Mechanical and Biologic Aortic Valves for Patients Age 55 to 70 Yearsaolo Stassano, Luigi Di Tommaso, Mario Monaco, Francesco Iorio, Paolo Pepino, Nicola Spampinato,
arlo Vosa
hile the durability of mechanical aortic valve (MV) replacements makes them more
ttractive for younger patients and the freedom from the need of anticoagulation makes
iologic valves (BV) more appealing for elderly patients, there is no clear guidance for patients
ge 55 to 70 years. Stassano and colleagues randomized over 300 patients to MV or BV with
mean follow-up of over 8 years. There was no difference in either perioperative or late
ortality. Valve failures and reoperations were more frequent in the BV group compared with
he MV group, but there were no differences in rates of thromboembolism, bleeding,
ndocarditis, and major adverse prosthesis-related events. After 13 years, the survival and
ajor complication rates except for valve reoperation were similar for middle-aged patients
hen randomized to MV or BV.
ditorial Comment: Peter H. Stone, p. 1869(continued on page A-32)
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eARDIAC IMAGING1872CACS and SPECT Provide Complementary Information for Risk Stratification0
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p <0.001 across CACS groups 
for all SPECT categoriesu Min Chang, Faisal Nabi, Jiaqiong Xu, Leif E. Peterson, Arup Achari, Craig M. Pratt,
ohn J. Mahmarian
hang and associates examined the relationship between coronary artery calcium score
CACS) and single-photon emission computed tomography (SPECT) results for predicting
ardiac events. Over 1,000 generally asymptomatic patients who had both studies performed
ithin a close time period were followed for a median of 7 years. Total cardiac events and
eath/myocardial infarction (MI) increased with both higher CACS and abnormal SPECT
esults. In patients with a normal SPECT, CACS added incremental prognostic information,
ith a 3.6-fold relative increase for any cardiac event when the CACS was severe (400)
ersus minimal (10). Separation of the survival curves occurred at 3 years after initial testing
or all cardiac events and at 5 years for death/MI. These results support performing a CACS
n patients at intermediate or high clinical risk for coronary artery disease who have a normal
PECT.ONGENITAL HEART DISEASE
1883tructural Abnormalities Common in the
Pulmonary Trunk in Patients With Tetralogy of Fallotlisabeth Bédard, Karen P. McCarthy, Konstantinos Dimopoulos, Georgios Giannakoulas,
ichael A. Gatzoulis, Siew Yen Ho
his study by Bédard and colleagues sought to determine if intrinsic histological
bnormalities of the pulmonary trunk (PT) are present from birth in patients with tetralogy of
allot (TOF). A total of 39 formalin-fixed necropsy heart specimens with TOF were
ompared to normal control hearts. Sections of the PT and aorta were studied by light
icroscopy, and histologic findings were graded according to severity. Grade 2 histological
hanges were often present in the PT of TOF patients, including medionecrosis, fibrosis,
yst-like formation, and abnormal elastic tissue configuration. Earlier studies found anatomic
bnormalities in the aortas of patients with TOF; these results show that abnormalities are
lso common in the PT.IABETES AND CARDIAC FUNCTION1891Altered Atrial Mitochondrial Function and Capacity in Diabetic Patientsthan J. Anderson, Alan P. Kypson, Evelio Rodriguez, Curtis A. Anderson, Eric J. Lehr, P. Darrell Neufer
nderson and colleagues studied the impact of diabetes on oxidant balance and mitochondrial
etabolism in the myocardium of patients with diabetes. Mitochondrial oxygen consumption
nd hydrogen peroxide (H2O2) emission were measured from samples of right atrial
ppendage obtained from patients undergoing cardiac surgery. The mitochondria from
atients with diabetes had a decreased capacity for glutamate and fatty acid-supported
espiration, increased content of triglycerides, depleted glutathione, and evidence of persistent
xidative stress. These findings demonstrate that the mitochondria in diabetic human hearts
ave impairments in their capacity to oxidize fatty acids and glutamate with increased H2O2
mission.
